Cellid, COVID-19 vaccine Korean stock
Aggiornato
Bullish
Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Trade attivo
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts. Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
Trade attivo
Space elevator~Trade chiuso: stop raggiunto
Events didn't pan out as I had expected. Too bad.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.